[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fpFyXUfeRfmWAdyrETFL_QumhFj8H8I5HQrWQkFn_kWc":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":69,"rows":76},"Zealand University Hospital",[4],230,false,43,3,162708,8,169,[14,17,19,22,24,26,29,32],{"name":15,"count":16},"Colorectal Cancer",9,{"name":18,"count":11},"Anesthesia, Local",{"name":20,"count":21},"Postoperative Pain",7,{"name":23,"count":21},"Ventral Hernia",{"name":25,"count":21},"Healthy",{"name":27,"count":28},"Quality of Life",6,{"name":30,"count":31},"Obesity",5,{"name":33,"count":31},"Delirium",[35,40,45,50,55,59,64],{"nctId":36,"briefTitle":37,"date":38,"intervention":39},"NCT05220800","Effects of Intravenous Administered Iron in Non-anemic Iron Deficient Patients With Colorectal Cancer","2024-03-01","Iron(III)isomaltoside",{"nctId":41,"briefTitle":42,"date":43,"intervention":44},"NCT03962920","Personalized Treatment of Urogenital Cancers Depends on the Microbiome","2025-05-01","Tigecycline 50 MG",{"nctId":46,"briefTitle":47,"date":48,"intervention":49},"NCT05909423","Combining Intratumoral Flu Vaccine and Systemic Pembrolizumab in Patients With Early pMMR Colorectal Cancer","2025-09-01","Influenza vaccine",{"nctId":51,"briefTitle":52,"date":53,"intervention":54},"NCT06145074","Examining Safety, Efficacy and Feasibility of Preoperative Propranolol in Patients With PDAC.","2026-12-31","Propranolol",{"nctId":56,"briefTitle":57,"date":53,"intervention":58},"NCT04330729","The Effect of Salicylate on Platelet Function in CKD (Chronic Kidney Disease) Patients Treated With Aranesp","Acetylsalicylic acid",{"nctId":60,"briefTitle":61,"date":62,"intervention":63},"NCT07386080","Carbergoline for Antipsychotic Induced Hyperprolactinemia.","2028-05-01","Cabergoline",{"nctId":65,"briefTitle":66,"date":67,"intervention":68},"NCT05248620","Prophylactic Antibiotic Treatment in Hemodialysis","2028-10","Amoxicillin Clavulanic 500\u002F125mg or placebo",[70,71,72,73,74,75],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[77,102,124,142,166,199,221,243,264,364,415,437,459,488,515,543,568,586,613,631,656,674,703,721,739,757,775,801,831,849,872,890,927,982,1008,1041,1059,1077,1095,1113,1131,1149,1167,1191,1209,1235,1253,1271,1300,1324,1349,1375,1400,1418,1444,1468,1492,1517,1614,1649,1677,1695,1721,1746,1771,1797,1824],{"intervention":63,"totalTrials":78,"cells":79},1,{"EARLY_PHASE1":80,"PHASE1":83,"PHASE2":85,"PHASE3":87,"PHASE4":89,"NA":100},{"trials":81,"activeCount":82},[],0,{"trials":84,"activeCount":82},[],{"trials":86,"activeCount":82},[],{"trials":88,"activeCount":82},[],{"trials":90,"activeCount":78,"soonestReadout":62},[91],{"nctId":60,"briefTitle":61,"status":92,"phases":93,"primaryCompletion":62,"completion":94,"start":95,"enrollment":96,"conditions":97,"interventions":99},"NOT_YET_RECRUITING",[74],"2029-05-01","2026-05-01",146,[98],"Scizophrenia",[63],{"trials":101,"activeCount":82},[],{"intervention":49,"totalTrials":78,"cells":103},{"EARLY_PHASE1":104,"PHASE1":106,"PHASE2":108,"PHASE3":118,"PHASE4":120,"NA":122},{"trials":105,"activeCount":82},[],{"trials":107,"activeCount":82},[],{"trials":109,"activeCount":78,"soonestReadout":48},[110],{"nctId":46,"briefTitle":47,"status":92,"phases":111,"primaryCompletion":48,"completion":112,"start":113,"enrollment":114,"conditions":115,"interventions":116},[72],"2028-09-01","2023-09-01",21,[15],[49,117],"Pembrolizumab",{"trials":119,"activeCount":82},[],{"trials":121,"activeCount":82},[],{"trials":123,"activeCount":82},[],{"intervention":117,"totalTrials":78,"cells":125},{"EARLY_PHASE1":126,"PHASE1":128,"PHASE2":130,"PHASE3":136,"PHASE4":138,"NA":140},{"trials":127,"activeCount":82},[],{"trials":129,"activeCount":82},[],{"trials":131,"activeCount":78,"soonestReadout":48},[132],{"nctId":46,"briefTitle":47,"status":92,"phases":133,"primaryCompletion":48,"completion":112,"start":113,"enrollment":114,"conditions":134,"interventions":135},[72],[15],[49,117],{"trials":137,"activeCount":82},[],{"trials":139,"activeCount":82},[],{"trials":141,"activeCount":82},[],{"intervention":54,"totalTrials":78,"cells":143},{"EARLY_PHASE1":144,"PHASE1":146,"PHASE2":148,"PHASE3":160,"PHASE4":162,"NA":164},{"trials":145,"activeCount":82},[],{"trials":147,"activeCount":82},[],{"trials":149,"activeCount":78,"soonestReadout":53},[150],{"nctId":51,"briefTitle":52,"status":151,"phases":152,"primaryCompletion":53,"completion":153,"start":154,"enrollment":155,"conditions":156,"interventions":159},"RECRUITING",[72],"2035-12-31","2024-03-20",30,[157,158],"Pancreatic Cancer","Surgery",[54],{"trials":161,"activeCount":82},[],{"trials":163,"activeCount":82},[],{"trials":165,"activeCount":82},[],{"intervention":39,"totalTrials":167,"cells":168},2,{"EARLY_PHASE1":169,"PHASE1":171,"PHASE2":173,"PHASE3":183,"PHASE4":185,"NA":187},{"trials":170,"activeCount":82},[],{"trials":172,"activeCount":82},[],{"trials":174,"activeCount":78,"soonestReadout":38},[175],{"nctId":36,"briefTitle":37,"status":92,"phases":176,"primaryCompletion":38,"completion":177,"start":178,"enrollment":179,"conditions":180,"interventions":182},[72],"2029-03-01","2022-03-01",134,[181,15],"Iron-deficiency",[39],{"trials":184,"activeCount":82},[],{"trials":186,"activeCount":82},[],{"trials":188,"activeCount":82},[189],{"nctId":190,"briefTitle":191,"status":192,"phases":193,"primaryCompletion":194,"completion":194,"start":178,"enrollment":195,"conditions":196,"interventions":198},"NCT05221957","Effects of Preoperative Correction of Anemia With Intravenously Iron in Colorectal Cancer Patients.","UNKNOWN",[75],"2023-12",200,[15,197,181],"Anemia",[39],{"intervention":44,"totalTrials":78,"cells":200},{"EARLY_PHASE1":201,"PHASE1":203,"PHASE2":205,"PHASE3":207,"PHASE4":209,"NA":211},{"trials":202,"activeCount":82},[],{"trials":204,"activeCount":82},[],{"trials":206,"activeCount":82},[],{"trials":208,"activeCount":82},[],{"trials":210,"activeCount":82},[],{"trials":212,"activeCount":78,"soonestReadout":43},[213],{"nctId":41,"briefTitle":42,"status":151,"phases":214,"primaryCompletion":43,"completion":215,"start":216,"enrollment":217,"conditions":218,"interventions":220},[75],"2027-05-01","2020-05-01",28,[219],"Microbial Disease",[44],{"intervention":68,"totalTrials":78,"cells":222},{"EARLY_PHASE1":223,"PHASE1":225,"PHASE2":227,"PHASE3":229,"PHASE4":231,"NA":233},{"trials":224,"activeCount":82},[],{"trials":226,"activeCount":82},[],{"trials":228,"activeCount":82},[],{"trials":230,"activeCount":82},[],{"trials":232,"activeCount":82},[],{"trials":234,"activeCount":78,"soonestReadout":67},[235],{"nctId":65,"briefTitle":66,"status":151,"phases":236,"primaryCompletion":67,"completion":237,"start":238,"enrollment":239,"conditions":240,"interventions":242},[75],"2029-05","2022-02-14",800,[241],"Hemodialysis",[68],{"intervention":58,"totalTrials":78,"cells":244},{"EARLY_PHASE1":245,"PHASE1":247,"PHASE2":249,"PHASE3":251,"PHASE4":253,"NA":255},{"trials":246,"activeCount":82},[],{"trials":248,"activeCount":82},[],{"trials":250,"activeCount":82},[],{"trials":252,"activeCount":82},[],{"trials":254,"activeCount":82},[],{"trials":256,"activeCount":78,"soonestReadout":53},[257],{"nctId":56,"briefTitle":57,"status":151,"phases":258,"primaryCompletion":53,"completion":53,"start":259,"enrollment":260,"conditions":261,"interventions":263},[75],"2020-04-15",60,[262],"Erythropoietin Adverse Reaction",[58],{"intervention":265,"totalTrials":11,"cells":266},"Saline",{"EARLY_PHASE1":267,"PHASE1":269,"PHASE2":271,"PHASE3":285,"PHASE4":287,"NA":362},{"trials":268,"activeCount":82},[],{"trials":270,"activeCount":82},[],{"trials":272,"activeCount":82},[273],{"nctId":274,"briefTitle":275,"status":192,"phases":276,"primaryCompletion":277,"completion":278,"start":279,"enrollment":280,"conditions":281,"interventions":283},"NCT04798612","Effect of Low-dose Interferon-alfa2a on Peri-operative Immune Suppression",[72],"2025-08-01","2025-12-01","2023-08-14",68,[282],"Colon Cancer",[284,265],"Pegasys",{"trials":286,"activeCount":82},[],{"trials":288,"activeCount":82},[289,301,313,323,332,341,350],{"nctId":290,"briefTitle":291,"status":292,"phases":293,"primaryCompletion":294,"completion":294,"start":295,"enrollment":296,"conditions":297,"interventions":299},"NCT03571490","Ultrasound-guided Transmuscular Quadratus Lumborum Block for Elective Laparoscopic Hand-assisted Nephrectomy and Robot Assisted Partiel Nephrectomy","COMPLETED",[74],"2019-06-24","2018-06-26",50,[20,298],"Ultrasound Guided Transmuscular Quadratus Lumborum Block",[300,265],"Ropivacaine",{"nctId":302,"briefTitle":303,"status":292,"phases":304,"primaryCompletion":305,"completion":306,"start":307,"enrollment":308,"conditions":309,"interventions":310},"NCT03570541","TQL-block for Laparoscopic Hemicolectomy",[74],"2020-12-05","2021-01-03","2018-06-28",69,[20],[300,311,312,265],"Acetaminophen","Morphine",{"nctId":314,"briefTitle":315,"status":292,"phases":316,"primaryCompletion":317,"completion":317,"start":318,"enrollment":319,"conditions":320,"interventions":321},"NCT03068260","Ultrasound-guided Transmuscular Quadratus Lumborum Block for Elective Caesarean Section.",[74],"2017-12-01","2017-03-15",72,[20],[300,265,311,322,312],"Ibuprofen 400Mg Tablet \u002F Celebra 100 Mg",{"nctId":324,"briefTitle":325,"status":292,"phases":326,"primaryCompletion":327,"completion":327,"start":328,"enrollment":260,"conditions":329,"interventions":331},"NCT02818140","Ultrasound-guided Transmuscular Quadratus Lumborum Block for Percutaneous Nephrolithotomy",[74],"2018-03","2016-07",[330],"Kidney Stone",[300,265],{"nctId":333,"briefTitle":334,"status":292,"phases":335,"primaryCompletion":336,"completion":336,"start":337,"enrollment":338,"conditions":339,"interventions":340},"NCT03663478","Continuous TQL Block for Elective Cesarean Section",[74],"2020-04-08","2018-09-04",32,[20,18],[300,265],{"nctId":342,"briefTitle":343,"status":292,"phases":344,"primaryCompletion":345,"completion":345,"start":346,"enrollment":347,"conditions":348,"interventions":349},"NCT03650998","Transmuscular Quadratus Lumborum Block for Total Laparoscopic Hysterectomy.",[74],"2019-12-01","2018-09-28",70,[20],[300,265],{"nctId":351,"briefTitle":352,"status":292,"phases":353,"primaryCompletion":354,"completion":355,"start":356,"enrollment":357,"conditions":358,"interventions":359},"NCT04818749","Combined Intravenous Dexamethasone and Dexmedetomidine as Adjuncts to Popliteal and Saphenous Nerve Blocks in Patients Undergoing Orthopaedic Surgery of the Foot and Ankle",[74],"2023-04-17","2023-05-17","2021-06-02",120,[18],[265,360,361],"Dexamethasone 12 mg","Dexamethasone 12 mg + dexmedetomidine 1 mcg\u002Fkg",{"trials":363,"activeCount":82},[],{"intervention":365,"totalTrials":9,"cells":366},"Isotonic Saline",{"EARLY_PHASE1":367,"PHASE1":369,"PHASE2":371,"PHASE3":397,"PHASE4":399,"NA":413},{"trials":368,"activeCount":82},[],{"trials":370,"activeCount":82},[],{"trials":372,"activeCount":82},[373,382],{"nctId":374,"briefTitle":375,"status":292,"phases":376,"primaryCompletion":377,"completion":377,"start":378,"enrollment":114,"conditions":379,"interventions":380},"NCT02488473","Does Perineural Dexmedetomidine Prolong Duration of a Nerve Block?",[72],"2015-09","2015-08",[25],[381,300,365],"Dexmedetomidine",{"nctId":383,"briefTitle":384,"status":192,"phases":385,"primaryCompletion":386,"completion":387,"start":388,"enrollment":389,"conditions":390,"interventions":391},"NCT03222323","Perineural Dexmedetomidine for Ulnar Nerve Block.",[72],"2018-01-01","2018-04-01","2017-07-17",22,[25],[392,393,394,395,396],"Dexmedetomidine perineurally","Ropivacaine 5mg\u002Fml","Ropivacaine 7.5mg\u002Fml","Dexmedetomidine systemically","Isotonic saline",{"trials":398,"activeCount":82},[],{"trials":400,"activeCount":82},[401],{"nctId":402,"briefTitle":403,"status":292,"phases":404,"primaryCompletion":405,"completion":405,"start":406,"enrollment":407,"conditions":408,"interventions":412},"NCT02957903","Sensory Distribution of Lateral Femoral Cutaneous Nerve Block",[74],"2016-12","2016-11",20,[409,18,410,411],"Nerve Block","Pain, Postoperative","Anatomical Distribution",[300,365],{"trials":414,"activeCount":82},[],{"intervention":311,"totalTrials":167,"cells":416},{"EARLY_PHASE1":417,"PHASE1":419,"PHASE2":421,"PHASE3":423,"PHASE4":425,"NA":435},{"trials":418,"activeCount":82},[],{"trials":420,"activeCount":82},[],{"trials":422,"activeCount":82},[],{"trials":424,"activeCount":82},[],{"trials":426,"activeCount":82},[427,431],{"nctId":302,"briefTitle":303,"status":292,"phases":428,"primaryCompletion":305,"completion":306,"start":307,"enrollment":308,"conditions":429,"interventions":430},[74],[20],[300,311,312,265],{"nctId":314,"briefTitle":315,"status":292,"phases":432,"primaryCompletion":317,"completion":317,"start":318,"enrollment":319,"conditions":433,"interventions":434},[74],[20],[300,265,311,322,312],{"trials":436,"activeCount":82},[],{"intervention":312,"totalTrials":167,"cells":438},{"EARLY_PHASE1":439,"PHASE1":441,"PHASE2":443,"PHASE3":445,"PHASE4":447,"NA":457},{"trials":440,"activeCount":82},[],{"trials":442,"activeCount":82},[],{"trials":444,"activeCount":82},[],{"trials":446,"activeCount":82},[],{"trials":448,"activeCount":82},[449,453],{"nctId":302,"briefTitle":303,"status":292,"phases":450,"primaryCompletion":305,"completion":306,"start":307,"enrollment":308,"conditions":451,"interventions":452},[74],[20],[300,311,312,265],{"nctId":314,"briefTitle":315,"status":292,"phases":454,"primaryCompletion":317,"completion":317,"start":318,"enrollment":319,"conditions":455,"interventions":456},[74],[20],[300,265,311,322,312],{"trials":458,"activeCount":82},[],{"intervention":360,"totalTrials":167,"cells":460},{"EARLY_PHASE1":461,"PHASE1":463,"PHASE2":465,"PHASE3":467,"PHASE4":469,"NA":486},{"trials":462,"activeCount":82},[],{"trials":464,"activeCount":82},[],{"trials":466,"activeCount":82},[],{"trials":468,"activeCount":82},[],{"trials":470,"activeCount":82},[471,482],{"nctId":472,"briefTitle":473,"status":292,"phases":474,"primaryCompletion":475,"completion":476,"start":477,"enrollment":478,"conditions":479,"interventions":480},"NCT04853446","Oral Dexamethasone as an Adjunct to a Brachial Plexus Block in Patients Undergoing Orthopaedic Surgery of the Forearm and Hand",[74],"2023-04-04","2023-05-04","2021-06-28",180,[18],[360,481],"Dexamethasone 24 mg",{"nctId":351,"briefTitle":352,"status":292,"phases":483,"primaryCompletion":354,"completion":355,"start":356,"enrollment":357,"conditions":484,"interventions":485},[74],[18],[265,360,361],{"trials":487,"activeCount":82},[],{"intervention":489,"totalTrials":78,"cells":490},"Pantoprazole + Placebo",{"EARLY_PHASE1":491,"PHASE1":493,"PHASE2":495,"PHASE3":497,"PHASE4":499,"NA":513},{"trials":492,"activeCount":82},[],{"trials":494,"activeCount":82},[],{"trials":496,"activeCount":82},[],{"trials":498,"activeCount":82},[],{"trials":500,"activeCount":82},[501],{"nctId":502,"briefTitle":503,"status":504,"phases":505,"primaryCompletion":506,"completion":507,"start":508,"enrollment":509,"conditions":510,"interventions":512},"NCT01373970","The Clinical Significance of Acid Rebound in Functional Dyspepsia","TERMINATED",[74],"2013-05","2013-09","2011-05",184,[511],"Functional Dyspepsia",[489],{"trials":514,"activeCount":82},[],{"intervention":516,"totalTrials":78,"cells":517},"Vivag Plus",{"EARLY_PHASE1":518,"PHASE1":520,"PHASE2":522,"PHASE3":524,"PHASE4":526,"NA":541},{"trials":519,"activeCount":82},[],{"trials":521,"activeCount":82},[],{"trials":523,"activeCount":82},[],{"trials":525,"activeCount":82},[],{"trials":527,"activeCount":82},[528],{"nctId":529,"briefTitle":530,"status":292,"phases":531,"primaryCompletion":532,"completion":533,"start":534,"enrollment":535,"conditions":536,"interventions":540},"NCT03843112","Modulating the Vaginal Microbiome After Implantation Failure",[74],"2021-01-05","2021-02-27","2019-03-01",74,[537,538,539],"Implantation Failure","Infertility, Female","Vaginal Flora Imbalance",[516],{"trials":542,"activeCount":82},[],{"intervention":544,"totalTrials":78,"cells":545},"Haloperidol",{"EARLY_PHASE1":546,"PHASE1":548,"PHASE2":550,"PHASE3":552,"PHASE4":554,"NA":566},{"trials":547,"activeCount":82},[],{"trials":549,"activeCount":82},[],{"trials":551,"activeCount":82},[],{"trials":553,"activeCount":82},[],{"trials":555,"activeCount":82},[556],{"nctId":557,"briefTitle":558,"status":192,"phases":559,"primaryCompletion":560,"completion":561,"start":562,"enrollment":563,"conditions":564,"interventions":565},"NCT03392376","Agents Intervening Against Delirium in Intensive Care Unit",[74],"2022-07-09","2023-07","2018-06-13",1000,[33],[544],{"trials":567,"activeCount":82},[],{"intervention":322,"totalTrials":78,"cells":569},{"EARLY_PHASE1":570,"PHASE1":572,"PHASE2":574,"PHASE3":576,"PHASE4":578,"NA":584},{"trials":571,"activeCount":82},[],{"trials":573,"activeCount":82},[],{"trials":575,"activeCount":82},[],{"trials":577,"activeCount":82},[],{"trials":579,"activeCount":82},[580],{"nctId":314,"briefTitle":315,"status":292,"phases":581,"primaryCompletion":317,"completion":317,"start":318,"enrollment":319,"conditions":582,"interventions":583},[74],[20],[300,265,311,322,312],{"trials":585,"activeCount":82},[],{"intervention":587,"totalTrials":78,"cells":588},"Saline 0.9%",{"EARLY_PHASE1":589,"PHASE1":591,"PHASE2":593,"PHASE3":595,"PHASE4":597,"NA":611},{"trials":590,"activeCount":82},[],{"trials":592,"activeCount":82},[],{"trials":594,"activeCount":82},[],{"trials":596,"activeCount":82},[],{"trials":598,"activeCount":82},[599],{"nctId":600,"briefTitle":601,"status":292,"phases":602,"primaryCompletion":603,"completion":603,"start":604,"enrollment":605,"conditions":606,"interventions":609},"NCT04248179","The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery.",[74],"2021-12-08","2019-11-29",36,[607,608],"Breast Cancer","Ductal Carcinoma in Situ",[300,587,610],"Sufentanil and PONV prophylaxis",{"trials":612,"activeCount":82},[],{"intervention":610,"totalTrials":78,"cells":614},{"EARLY_PHASE1":615,"PHASE1":617,"PHASE2":619,"PHASE3":621,"PHASE4":623,"NA":629},{"trials":616,"activeCount":82},[],{"trials":618,"activeCount":82},[],{"trials":620,"activeCount":82},[],{"trials":622,"activeCount":82},[],{"trials":624,"activeCount":82},[625],{"nctId":600,"briefTitle":601,"status":292,"phases":626,"primaryCompletion":603,"completion":603,"start":604,"enrollment":605,"conditions":627,"interventions":628},[74],[607,608],[300,587,610],{"trials":630,"activeCount":82},[],{"intervention":632,"totalTrials":78,"cells":633},"Pasireotide 0.3 MG\u002FML",{"EARLY_PHASE1":634,"PHASE1":636,"PHASE2":638,"PHASE3":640,"PHASE4":642,"NA":654},{"trials":635,"activeCount":82},[],{"trials":637,"activeCount":82},[],{"trials":639,"activeCount":82},[],{"trials":641,"activeCount":82},[],{"trials":643,"activeCount":82},[644],{"nctId":645,"briefTitle":646,"status":192,"phases":647,"primaryCompletion":648,"completion":649,"start":650,"enrollment":31,"conditions":651,"interventions":653},"NCT03514576","Pasireotide in the Treatment of Hypoglycemia Following Gastric Bypass Surgery",[74],"2018-08-01","2018-11-01","2018-06-01",[652],"Hypoglycemia, Reactive",[632],{"trials":655,"activeCount":82},[],{"intervention":481,"totalTrials":78,"cells":657},{"EARLY_PHASE1":658,"PHASE1":660,"PHASE2":662,"PHASE3":664,"PHASE4":666,"NA":672},{"trials":659,"activeCount":82},[],{"trials":661,"activeCount":82},[],{"trials":663,"activeCount":82},[],{"trials":665,"activeCount":82},[],{"trials":667,"activeCount":82},[668],{"nctId":472,"briefTitle":473,"status":292,"phases":669,"primaryCompletion":475,"completion":476,"start":477,"enrollment":478,"conditions":670,"interventions":671},[74],[18],[360,481],{"trials":673,"activeCount":82},[],{"intervention":675,"totalTrials":78,"cells":676},"Glucobay",{"EARLY_PHASE1":677,"PHASE1":679,"PHASE2":681,"PHASE3":683,"PHASE4":685,"NA":701},{"trials":678,"activeCount":82},[],{"trials":680,"activeCount":82},[],{"trials":682,"activeCount":82},[],{"trials":684,"activeCount":82},[],{"trials":686,"activeCount":82},[687],{"nctId":688,"briefTitle":689,"status":292,"phases":690,"primaryCompletion":691,"completion":691,"start":692,"enrollment":693,"conditions":694,"interventions":696},"NCT02527993","Treatment of Hypoglycemia Following Gastric Bypass Surgery",[74],"2017-04-08","2015-10",11,[695,30,158],"Hypoglycemia",[675,697,698,699,700],"Januvia","Verapamil HEXAL","Victoza","Signifor",{"trials":702,"activeCount":82},[],{"intervention":697,"totalTrials":78,"cells":704},{"EARLY_PHASE1":705,"PHASE1":707,"PHASE2":709,"PHASE3":711,"PHASE4":713,"NA":719},{"trials":706,"activeCount":82},[],{"trials":708,"activeCount":82},[],{"trials":710,"activeCount":82},[],{"trials":712,"activeCount":82},[],{"trials":714,"activeCount":82},[715],{"nctId":688,"briefTitle":689,"status":292,"phases":716,"primaryCompletion":691,"completion":691,"start":692,"enrollment":693,"conditions":717,"interventions":718},[74],[695,30,158],[675,697,698,699,700],{"trials":720,"activeCount":82},[],{"intervention":698,"totalTrials":78,"cells":722},{"EARLY_PHASE1":723,"PHASE1":725,"PHASE2":727,"PHASE3":729,"PHASE4":731,"NA":737},{"trials":724,"activeCount":82},[],{"trials":726,"activeCount":82},[],{"trials":728,"activeCount":82},[],{"trials":730,"activeCount":82},[],{"trials":732,"activeCount":82},[733],{"nctId":688,"briefTitle":689,"status":292,"phases":734,"primaryCompletion":691,"completion":691,"start":692,"enrollment":693,"conditions":735,"interventions":736},[74],[695,30,158],[675,697,698,699,700],{"trials":738,"activeCount":82},[],{"intervention":699,"totalTrials":78,"cells":740},{"EARLY_PHASE1":741,"PHASE1":743,"PHASE2":745,"PHASE3":747,"PHASE4":749,"NA":755},{"trials":742,"activeCount":82},[],{"trials":744,"activeCount":82},[],{"trials":746,"activeCount":82},[],{"trials":748,"activeCount":82},[],{"trials":750,"activeCount":82},[751],{"nctId":688,"briefTitle":689,"status":292,"phases":752,"primaryCompletion":691,"completion":691,"start":692,"enrollment":693,"conditions":753,"interventions":754},[74],[695,30,158],[675,697,698,699,700],{"trials":756,"activeCount":82},[],{"intervention":700,"totalTrials":78,"cells":758},{"EARLY_PHASE1":759,"PHASE1":761,"PHASE2":763,"PHASE3":765,"PHASE4":767,"NA":773},{"trials":760,"activeCount":82},[],{"trials":762,"activeCount":82},[],{"trials":764,"activeCount":82},[],{"trials":766,"activeCount":82},[],{"trials":768,"activeCount":82},[769],{"nctId":688,"briefTitle":689,"status":292,"phases":770,"primaryCompletion":691,"completion":691,"start":692,"enrollment":693,"conditions":771,"interventions":772},[74],[695,30,158],[675,697,698,699,700],{"trials":774,"activeCount":82},[],{"intervention":776,"totalTrials":78,"cells":777},"chenodeoxycholic acid",{"EARLY_PHASE1":778,"PHASE1":780,"PHASE2":782,"PHASE3":784,"PHASE4":786,"NA":799},{"trials":779,"activeCount":82},[],{"trials":781,"activeCount":82},[],{"trials":783,"activeCount":82},[],{"trials":785,"activeCount":82},[],{"trials":787,"activeCount":82},[788],{"nctId":789,"briefTitle":790,"status":292,"phases":791,"primaryCompletion":792,"completion":792,"start":793,"enrollment":794,"conditions":795,"interventions":798},"NCT03168555","Changes in Bile Acid Homeostasis and Stool Habits After Cholecystectomy",[74],"2019-05-15","2017-06-22",23,[796,797],"Bile Acid Malabsorption","Cholelithiasis",[776],{"trials":800,"activeCount":82},[],{"intervention":802,"totalTrials":78,"cells":803},"Donepezil",{"EARLY_PHASE1":804,"PHASE1":806,"PHASE2":808,"PHASE3":810,"PHASE4":812,"NA":829},{"trials":805,"activeCount":82},[],{"trials":807,"activeCount":82},[],{"trials":809,"activeCount":82},[],{"trials":811,"activeCount":82},[],{"trials":813,"activeCount":82},[814],{"nctId":815,"briefTitle":816,"status":292,"phases":817,"primaryCompletion":818,"completion":818,"start":819,"enrollment":820,"conditions":821,"interventions":827},"NCT04117178","Monitoring Anti-Dementia Drugs by Serum Levels",[74],"2023-02-16","2020-02-04",132,[822,823,824,825,826],"Dementia","Dementia With Lewy Bodies","Dementia in Parkinsons Disease","Dementia Alzheimers","Alzheimer Disease",[802,828],"Memantine",{"trials":830,"activeCount":82},[],{"intervention":828,"totalTrials":78,"cells":832},{"EARLY_PHASE1":833,"PHASE1":835,"PHASE2":837,"PHASE3":839,"PHASE4":841,"NA":847},{"trials":834,"activeCount":82},[],{"trials":836,"activeCount":82},[],{"trials":838,"activeCount":82},[],{"trials":840,"activeCount":82},[],{"trials":842,"activeCount":82},[843],{"nctId":815,"briefTitle":816,"status":292,"phases":844,"primaryCompletion":818,"completion":818,"start":819,"enrollment":820,"conditions":845,"interventions":846},[74],[822,823,824,825,826],[802,828],{"trials":848,"activeCount":82},[],{"intervention":850,"totalTrials":78,"cells":851},"esomeprazole",{"EARLY_PHASE1":852,"PHASE1":854,"PHASE2":856,"PHASE3":858,"PHASE4":860,"NA":870},{"trials":853,"activeCount":82},[],{"trials":855,"activeCount":82},[],{"trials":857,"activeCount":82},[],{"trials":859,"activeCount":82},[],{"trials":861,"activeCount":82},[862],{"nctId":863,"briefTitle":864,"status":192,"phases":865,"completion":866,"start":867,"conditions":868,"interventions":869},"NCT00526006","PPI-Rebound-Trial. A Study of the Clinical Relevance of the Acid Rebound Phenomena",[74],"2008-03","2007-09",[25],[850],{"trials":871,"activeCount":82},[],{"intervention":361,"totalTrials":78,"cells":873},{"EARLY_PHASE1":874,"PHASE1":876,"PHASE2":878,"PHASE3":880,"PHASE4":882,"NA":888},{"trials":875,"activeCount":82},[],{"trials":877,"activeCount":82},[],{"trials":879,"activeCount":82},[],{"trials":881,"activeCount":82},[],{"trials":883,"activeCount":82},[884],{"nctId":351,"briefTitle":352,"status":292,"phases":885,"primaryCompletion":354,"completion":355,"start":356,"enrollment":357,"conditions":886,"interventions":887},[74],[18],[265,360,361],{"trials":889,"activeCount":82},[],{"intervention":891,"totalTrials":167,"cells":892},"Melatonin",{"EARLY_PHASE1":893,"PHASE1":895,"PHASE2":907,"PHASE3":909,"PHASE4":923,"NA":925},{"trials":894,"activeCount":82},[],{"trials":896,"activeCount":82},[897],{"nctId":898,"briefTitle":899,"status":292,"phases":900,"primaryCompletion":901,"start":902,"enrollment":903,"conditions":904,"interventions":906},"NCT02224937","MELATOX: Evaluation of Percutaneous Dissolvement of Melatonin When Used as Sunscreen; a Randomized, Placebo Controlled, Double-blind Crossover Study on Healthy Volunteers.",[71],"2014-02","2013-12",10,[905],"Solar Skin Damage",[891],{"trials":908,"activeCount":82},[],{"trials":910,"activeCount":82},[911],{"nctId":912,"briefTitle":913,"status":292,"phases":914,"primaryCompletion":915,"completion":916,"start":917,"enrollment":918,"conditions":919,"interventions":922},"NCT02451293","The Effect of MElatonin on Depression, Anxiety, CIrcadian and Sleep Disturbances in Patients After Acute Myocardial Syndrome",[72,73],"2017-08-18","2018-07-20","2016-01-18",252,[920,921],"Depression","Acute Coronary Syndrome",[891],{"trials":924,"activeCount":82},[],{"trials":926,"activeCount":82},[],{"intervention":928,"totalTrials":929,"cells":930},"Calcium electroporation",4,{"EARLY_PHASE1":931,"PHASE1":933,"PHASE2":953,"PHASE3":976,"PHASE4":978,"NA":980},{"trials":932,"activeCount":82},[],{"trials":934,"activeCount":82},[935,945],{"nctId":936,"briefTitle":937,"status":292,"phases":938,"primaryCompletion":939,"completion":940,"start":941,"enrollment":28,"conditions":942,"interventions":944},"NCT03542214","Calcium Electroporation for the Treatment of Colorectal Cancer",[71],"2020-10-01","2021-01-01","2018-04-24",[943],"Colorectal Cancer Stage IV",[928],{"nctId":946,"briefTitle":947,"status":192,"phases":948,"primaryCompletion":216,"completion":949,"start":649,"enrollment":950,"conditions":951,"interventions":952},"NCT03694080","Calcium Electroporation for Early Colorectal Cancer",[71],"2020-09-01",24,[15],[928],{"trials":954,"activeCount":82},[955,966],{"nctId":956,"briefTitle":957,"status":292,"phases":958,"primaryCompletion":959,"completion":960,"start":961,"enrollment":962,"conditions":963,"interventions":965},"NCT04259658","Histopathologic Effect of Calcium Electroporation on Cancer in the Skin",[72],"2022-10-19","2023-07-27","2020-04-20",17,[964],"Cancer",[928],{"nctId":967,"briefTitle":968,"status":192,"phases":969,"primaryCompletion":970,"completion":971,"start":972,"enrollment":973,"conditions":974,"interventions":975},"NCT04225767","Calcium Electroporation as a Treatment for Cutaneous and Subcutaneous Malignant Tumours",[72],"2023-01-01","2023-08-01","2020-02-18",19,[964],[928],{"trials":977,"activeCount":82},[],{"trials":979,"activeCount":82},[],{"trials":981,"activeCount":82},[],{"intervention":983,"totalTrials":78,"cells":984},"SGLT2 inhibitor",{"EARLY_PHASE1":985,"PHASE1":987,"PHASE2":989,"PHASE3":1002,"PHASE4":1004,"NA":1006},{"trials":986,"activeCount":82},[],{"trials":988,"activeCount":82},[],{"trials":990,"activeCount":82},[991],{"nctId":992,"briefTitle":993,"status":192,"phases":994,"primaryCompletion":995,"completion":996,"start":997,"enrollment":950,"conditions":998,"interventions":1001},"NCT05314725","Treatment With SGLT-2 Inhibitor for Postoperative Hyperglycemia in Acute Abdominal Surgery - a Randomized Trial",[72],"2023-05-01","2023-06-01","2022-06-01",[999,1000],"Postoperative Hyperglycemia","Stress Hyperglycemia",[983],{"trials":1003,"activeCount":82},[],{"trials":1005,"activeCount":82},[],{"trials":1007,"activeCount":82},[],{"intervention":1009,"totalTrials":78,"cells":1010},"Capecitabine",{"EARLY_PHASE1":1011,"PHASE1":1013,"PHASE2":1015,"PHASE3":1035,"PHASE4":1037,"NA":1039},{"trials":1012,"activeCount":82},[],{"trials":1014,"activeCount":82},[],{"trials":1016,"activeCount":82},[1017],{"nctId":1018,"briefTitle":1019,"status":192,"phases":1020,"primaryCompletion":1021,"completion":1022,"start":1023,"enrollment":1024,"conditions":1025,"interventions":1032},"NCT03280407","NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal Cancer",[72],"2018-12-31","2024-12-31","2017-03-01",124,[1026,15,1027,1028,1029,1030,1031],"Colorectal Neoplasm","Rectal Neoplasms","Chemotherapy Effect","Intestinal Disease","Intestinal Neoplasms","Rectal Cancer",[1009,1033,1034],"FOLFOX regimen","CAPOX",{"trials":1036,"activeCount":82},[],{"trials":1038,"activeCount":82},[],{"trials":1040,"activeCount":82},[],{"intervention":1033,"totalTrials":78,"cells":1042},{"EARLY_PHASE1":1043,"PHASE1":1045,"PHASE2":1047,"PHASE3":1053,"PHASE4":1055,"NA":1057},{"trials":1044,"activeCount":82},[],{"trials":1046,"activeCount":82},[],{"trials":1048,"activeCount":82},[1049],{"nctId":1018,"briefTitle":1019,"status":192,"phases":1050,"primaryCompletion":1021,"completion":1022,"start":1023,"enrollment":1024,"conditions":1051,"interventions":1052},[72],[1026,15,1027,1028,1029,1030,1031],[1009,1033,1034],{"trials":1054,"activeCount":82},[],{"trials":1056,"activeCount":82},[],{"trials":1058,"activeCount":82},[],{"intervention":1034,"totalTrials":78,"cells":1060},{"EARLY_PHASE1":1061,"PHASE1":1063,"PHASE2":1065,"PHASE3":1071,"PHASE4":1073,"NA":1075},{"trials":1062,"activeCount":82},[],{"trials":1064,"activeCount":82},[],{"trials":1066,"activeCount":82},[1067],{"nctId":1018,"briefTitle":1019,"status":192,"phases":1068,"primaryCompletion":1021,"completion":1022,"start":1023,"enrollment":1024,"conditions":1069,"interventions":1070},[72],[1026,15,1027,1028,1029,1030,1031],[1009,1033,1034],{"trials":1072,"activeCount":82},[],{"trials":1074,"activeCount":82},[],{"trials":1076,"activeCount":82},[],{"intervention":381,"totalTrials":78,"cells":1078},{"EARLY_PHASE1":1079,"PHASE1":1081,"PHASE2":1083,"PHASE3":1089,"PHASE4":1091,"NA":1093},{"trials":1080,"activeCount":82},[],{"trials":1082,"activeCount":82},[],{"trials":1084,"activeCount":82},[1085],{"nctId":374,"briefTitle":375,"status":292,"phases":1086,"primaryCompletion":377,"completion":377,"start":378,"enrollment":114,"conditions":1087,"interventions":1088},[72],[25],[381,300,365],{"trials":1090,"activeCount":82},[],{"trials":1092,"activeCount":82},[],{"trials":1094,"activeCount":82},[],{"intervention":392,"totalTrials":78,"cells":1096},{"EARLY_PHASE1":1097,"PHASE1":1099,"PHASE2":1101,"PHASE3":1107,"PHASE4":1109,"NA":1111},{"trials":1098,"activeCount":82},[],{"trials":1100,"activeCount":82},[],{"trials":1102,"activeCount":82},[1103],{"nctId":383,"briefTitle":384,"status":192,"phases":1104,"primaryCompletion":386,"completion":387,"start":388,"enrollment":389,"conditions":1105,"interventions":1106},[72],[25],[392,393,394,395,396],{"trials":1108,"activeCount":82},[],{"trials":1110,"activeCount":82},[],{"trials":1112,"activeCount":82},[],{"intervention":393,"totalTrials":78,"cells":1114},{"EARLY_PHASE1":1115,"PHASE1":1117,"PHASE2":1119,"PHASE3":1125,"PHASE4":1127,"NA":1129},{"trials":1116,"activeCount":82},[],{"trials":1118,"activeCount":82},[],{"trials":1120,"activeCount":82},[1121],{"nctId":383,"briefTitle":384,"status":192,"phases":1122,"primaryCompletion":386,"completion":387,"start":388,"enrollment":389,"conditions":1123,"interventions":1124},[72],[25],[392,393,394,395,396],{"trials":1126,"activeCount":82},[],{"trials":1128,"activeCount":82},[],{"trials":1130,"activeCount":82},[],{"intervention":394,"totalTrials":78,"cells":1132},{"EARLY_PHASE1":1133,"PHASE1":1135,"PHASE2":1137,"PHASE3":1143,"PHASE4":1145,"NA":1147},{"trials":1134,"activeCount":82},[],{"trials":1136,"activeCount":82},[],{"trials":1138,"activeCount":82},[1139],{"nctId":383,"briefTitle":384,"status":192,"phases":1140,"primaryCompletion":386,"completion":387,"start":388,"enrollment":389,"conditions":1141,"interventions":1142},[72],[25],[392,393,394,395,396],{"trials":1144,"activeCount":82},[],{"trials":1146,"activeCount":82},[],{"trials":1148,"activeCount":82},[],{"intervention":395,"totalTrials":78,"cells":1150},{"EARLY_PHASE1":1151,"PHASE1":1153,"PHASE2":1155,"PHASE3":1161,"PHASE4":1163,"NA":1165},{"trials":1152,"activeCount":82},[],{"trials":1154,"activeCount":82},[],{"trials":1156,"activeCount":82},[1157],{"nctId":383,"briefTitle":384,"status":192,"phases":1158,"primaryCompletion":386,"completion":387,"start":388,"enrollment":389,"conditions":1159,"interventions":1160},[72],[25],[392,393,394,395,396],{"trials":1162,"activeCount":82},[],{"trials":1164,"activeCount":82},[],{"trials":1166,"activeCount":82},[],{"intervention":1168,"totalTrials":78,"cells":1169},"Ropivacaine 20ml 5mg\u002Fml+ Clonidine 150ug",{"EARLY_PHASE1":1170,"PHASE1":1172,"PHASE2":1174,"PHASE3":1185,"PHASE4":1187,"NA":1189},{"trials":1171,"activeCount":82},[],{"trials":1173,"activeCount":82},[],{"trials":1175,"activeCount":82},[1176],{"nctId":1177,"briefTitle":1178,"status":292,"phases":1179,"primaryCompletion":1180,"completion":1180,"start":1181,"enrollment":114,"conditions":1182,"interventions":1183},"NCT02444559","Does Perineural Clonidine Prolong Duration of a Nerve Block?",[72],"2015-06","2015-05",[25],[1168,1184],"Ropivacaine 20ml 5mg\u002Fml+ Placebo",{"trials":1186,"activeCount":82},[],{"trials":1188,"activeCount":82},[],{"trials":1190,"activeCount":82},[],{"intervention":1184,"totalTrials":78,"cells":1192},{"EARLY_PHASE1":1193,"PHASE1":1195,"PHASE2":1197,"PHASE3":1203,"PHASE4":1205,"NA":1207},{"trials":1194,"activeCount":82},[],{"trials":1196,"activeCount":82},[],{"trials":1198,"activeCount":82},[1199],{"nctId":1177,"briefTitle":1178,"status":292,"phases":1200,"primaryCompletion":1180,"completion":1180,"start":1181,"enrollment":114,"conditions":1201,"interventions":1202},[72],[25],[1168,1184],{"trials":1204,"activeCount":82},[],{"trials":1206,"activeCount":82},[],{"trials":1208,"activeCount":82},[],{"intervention":1210,"totalTrials":78,"cells":1211},"Perineural dexamethasone",{"EARLY_PHASE1":1212,"PHASE1":1214,"PHASE2":1216,"PHASE3":1229,"PHASE4":1231,"NA":1233},{"trials":1213,"activeCount":82},[],{"trials":1215,"activeCount":82},[],{"trials":1217,"activeCount":82},[1218],{"nctId":1219,"briefTitle":1220,"status":292,"phases":1221,"primaryCompletion":1222,"completion":1222,"start":1223,"enrollment":1224,"conditions":1225,"interventions":1226},"NCT04817982","Does Perineural Dexamethasone Increase the Duration of an Ulnar Nerve Block When Controlling for Systemic Effects?",[72],"2021-05-15","2021-04-07",16,[18],[1210,1227,1228],"Lidocaine","Systemic dexamethasone",{"trials":1230,"activeCount":82},[],{"trials":1232,"activeCount":82},[],{"trials":1234,"activeCount":82},[],{"intervention":1227,"totalTrials":78,"cells":1236},{"EARLY_PHASE1":1237,"PHASE1":1239,"PHASE2":1241,"PHASE3":1247,"PHASE4":1249,"NA":1251},{"trials":1238,"activeCount":82},[],{"trials":1240,"activeCount":82},[],{"trials":1242,"activeCount":82},[1243],{"nctId":1219,"briefTitle":1220,"status":292,"phases":1244,"primaryCompletion":1222,"completion":1222,"start":1223,"enrollment":1224,"conditions":1245,"interventions":1246},[72],[18],[1210,1227,1228],{"trials":1248,"activeCount":82},[],{"trials":1250,"activeCount":82},[],{"trials":1252,"activeCount":82},[],{"intervention":1228,"totalTrials":78,"cells":1254},{"EARLY_PHASE1":1255,"PHASE1":1257,"PHASE2":1259,"PHASE3":1265,"PHASE4":1267,"NA":1269},{"trials":1256,"activeCount":82},[],{"trials":1258,"activeCount":82},[],{"trials":1260,"activeCount":82},[1261],{"nctId":1219,"briefTitle":1220,"status":292,"phases":1262,"primaryCompletion":1222,"completion":1222,"start":1223,"enrollment":1224,"conditions":1263,"interventions":1264},[72],[18],[1210,1227,1228],{"trials":1266,"activeCount":82},[],{"trials":1268,"activeCount":82},[],{"trials":1270,"activeCount":82},[],{"intervention":1272,"totalTrials":78,"cells":1273},"Electrochemotherapy with bleomycin",{"EARLY_PHASE1":1274,"PHASE1":1276,"PHASE2":1278,"PHASE3":1294,"PHASE4":1296,"NA":1298},{"trials":1275,"activeCount":82},[],{"trials":1277,"activeCount":82},[],{"trials":1279,"activeCount":82},[1280],{"nctId":1281,"briefTitle":1282,"status":192,"phases":1283,"primaryCompletion":1284,"completion":1285,"start":1286,"enrollment":1287,"conditions":1288,"interventions":1293},"NCT03040180","Endoscopic Assisted Electrochemotherapy in Addition to Neoadjuvant Treatment of Locally Advanced Rectal Cancer",[72],"2019-06","2019-09","2017-01",40,[1289,1290,1291,1292],"Locally Advanced Rectal Cancer","Electrochemotherapy","Neoadjuvant Therapy","Down Staging",[1272],{"trials":1295,"activeCount":82},[],{"trials":1297,"activeCount":82},[],{"trials":1299,"activeCount":82},[],{"intervention":1301,"totalTrials":78,"cells":1302},"Influenza Vaccines",{"EARLY_PHASE1":1303,"PHASE1":1305,"PHASE2":1307,"PHASE3":1318,"PHASE4":1320,"NA":1322},{"trials":1304,"activeCount":82},[],{"trials":1306,"activeCount":82},[],{"trials":1308,"activeCount":82},[1309],{"nctId":1310,"briefTitle":1311,"status":292,"phases":1312,"primaryCompletion":1313,"completion":1314,"start":1315,"enrollment":903,"conditions":1316,"interventions":1317},"NCT04591379","Intratumoral Influenza Vaccine for Early Colorectal Cancer",[72],"2021-09-22","2021-11-01","2021-02-26",[15],[1301],{"trials":1319,"activeCount":82},[],{"trials":1321,"activeCount":82},[],{"trials":1323,"activeCount":82},[],{"intervention":1325,"totalTrials":78,"cells":1326},"Metformin Hydrochloride",{"EARLY_PHASE1":1327,"PHASE1":1329,"PHASE2":1331,"PHASE3":1343,"PHASE4":1345,"NA":1347},{"trials":1328,"activeCount":82},[],{"trials":1330,"activeCount":82},[],{"trials":1332,"activeCount":82},[1333],{"nctId":1334,"briefTitle":1335,"status":292,"phases":1336,"primaryCompletion":1337,"completion":1338,"start":1339,"enrollment":1340,"conditions":1341,"interventions":1342},"NCT03359681","Metformin Treatment for Colon Cancer",[72],"2021-09-02","2021-10-04","2018-07-10",48,[282],[1325],{"trials":1344,"activeCount":82},[],{"trials":1346,"activeCount":82},[],{"trials":1348,"activeCount":82},[],{"intervention":1350,"totalTrials":78,"cells":1351},"therapeutic endoscopy with metronidazole and fosfomycin disodium",{"EARLY_PHASE1":1352,"PHASE1":1354,"PHASE2":1356,"PHASE3":1369,"PHASE4":1371,"NA":1373},{"trials":1353,"activeCount":82},[],{"trials":1355,"activeCount":82},[],{"trials":1357,"activeCount":82},[1358],{"nctId":1359,"briefTitle":1360,"status":292,"phases":1361,"primaryCompletion":1362,"completion":1363,"start":1364,"enrollment":217,"conditions":1365,"interventions":1368},"NCT04312360","Preoperative Endoscopic Treatment With Fosfomycin and Metronidazole in Patients With Right-sided Colon Cancer and Colon Adenoma (MEFO-trial)",[72],"2022-04-13","2023-07-01","2020-01-16",[1366,1367],"Right-sided Colon Cancer","Right-sided Colon Adenoma",[1350],{"trials":1370,"activeCount":82},[],{"trials":1372,"activeCount":82},[],{"trials":1374,"activeCount":82},[],{"intervention":1376,"totalTrials":78,"cells":1377},"Mablet 360 mg",{"EARLY_PHASE1":1378,"PHASE1":1380,"PHASE2":1382,"PHASE3":1394,"PHASE4":1396,"NA":1398},{"trials":1379,"activeCount":82},[],{"trials":1381,"activeCount":82},[],{"trials":1383,"activeCount":82},[1384],{"nctId":1385,"briefTitle":1386,"status":292,"phases":1387,"primaryCompletion":1388,"completion":1388,"start":1389,"enrollment":605,"conditions":1390,"interventions":1393},"NCT02216877","Magnesium Supplementation for Hypomagnesemia in Chronic Kidney Disease",[71,72],"2015-04","2014-08",[1391,1392],"Chronic Kidney Disease","Hypomagnesemia",[1376],{"trials":1395,"activeCount":82},[],{"trials":1397,"activeCount":82},[],{"trials":1399,"activeCount":82},[],{"intervention":284,"totalTrials":78,"cells":1401},{"EARLY_PHASE1":1402,"PHASE1":1404,"PHASE2":1406,"PHASE3":1412,"PHASE4":1414,"NA":1416},{"trials":1403,"activeCount":82},[],{"trials":1405,"activeCount":82},[],{"trials":1407,"activeCount":82},[1408],{"nctId":274,"briefTitle":275,"status":192,"phases":1409,"primaryCompletion":277,"completion":278,"start":279,"enrollment":280,"conditions":1410,"interventions":1411},[72],[282],[284,265],{"trials":1413,"activeCount":82},[],{"trials":1415,"activeCount":82},[],{"trials":1417,"activeCount":82},[],{"intervention":1419,"totalTrials":78,"cells":1420},"Cannabidiol 100 MG\u002FML",{"EARLY_PHASE1":1421,"PHASE1":1423,"PHASE2":1425,"PHASE3":1438,"PHASE4":1440,"NA":1442},{"trials":1422,"activeCount":82},[],{"trials":1424,"activeCount":82},[],{"trials":1426,"activeCount":82},[1427],{"nctId":1428,"briefTitle":1429,"status":192,"phases":1430,"primaryCompletion":1431,"completion":1432,"start":1433,"enrollment":1434,"conditions":1435,"interventions":1437},"NCT04582591","Cannabidiol for Prevention of Chemotherapy-induced Peripheral Neuropathy",[72],"2022-01-05","2023-08-30","2021-03-03",54,[1436],"Chemotherapy-induced Peripheral Neuropathy",[1419],{"trials":1439,"activeCount":82},[],{"trials":1441,"activeCount":82},[],{"trials":1443,"activeCount":82},[],{"intervention":1445,"totalTrials":78,"cells":1446},"GM-CSF, fosfomycin and metronidazole",{"EARLY_PHASE1":1447,"PHASE1":1449,"PHASE2":1451,"PHASE3":1462,"PHASE4":1464,"NA":1466},{"trials":1448,"activeCount":82},[],{"trials":1450,"activeCount":82},[],{"trials":1452,"activeCount":82},[1453],{"nctId":1454,"briefTitle":1455,"status":192,"phases":1456,"primaryCompletion":194,"completion":194,"start":1457,"enrollment":1458,"conditions":1459,"interventions":1461},"NCT04979832","GM-CSF, Fosfomycin and Metronidazole for Pouchitis in Ulcerative Colitis Patients After Restorative IPAA Surgery",[71,72],"2021-09-06",18,[1460],"Pouchitis",[1445],{"trials":1463,"activeCount":82},[],{"trials":1465,"activeCount":82},[],{"trials":1467,"activeCount":82},[],{"intervention":1469,"totalTrials":78,"cells":1470},"Bleomycin",{"EARLY_PHASE1":1471,"PHASE1":1473,"PHASE2":1484,"PHASE3":1486,"PHASE4":1488,"NA":1490},{"trials":1472,"activeCount":82},[],{"trials":1474,"activeCount":82},[1475],{"nctId":1476,"briefTitle":1477,"status":192,"phases":1478,"primaryCompletion":940,"completion":1479,"start":1480,"enrollment":11,"conditions":1481,"interventions":1483},"NCT04139070","Electrochemotherapy for Non-curable Gastric Cancer",[71],"2021-07-01","2020-06-15",[1482],"Gastric Cancer",[1469],{"trials":1485,"activeCount":82},[],{"trials":1487,"activeCount":82},[],{"trials":1489,"activeCount":82},[],{"trials":1491,"activeCount":82},[],{"intervention":1493,"totalTrials":78,"cells":1494},"A 06 ad",{"EARLY_PHASE1":1495,"PHASE1":1497,"PHASE2":1509,"PHASE3":1511,"PHASE4":1513,"NA":1515},{"trials":1496,"activeCount":82},[],{"trials":1498,"activeCount":82},[1499],{"nctId":1500,"briefTitle":1501,"status":192,"phases":1502,"primaryCompletion":1503,"completion":1504,"start":1505,"enrollment":1224,"conditions":1506,"interventions":1508},"NCT03904303","Test of a New Gel-based Colon Cleansing Agent Compared to Moviprep",[71],"2019-12-31","2020-12-31","2019-06-01",[1507],"Pharmacological Action",[1493],{"trials":1510,"activeCount":82},[],{"trials":1512,"activeCount":82},[],{"trials":1514,"activeCount":82},[],{"trials":1516,"activeCount":82},[],{"intervention":300,"totalTrials":1518,"cells":1519},14,{"EARLY_PHASE1":1520,"PHASE1":1522,"PHASE2":1524,"PHASE3":1540,"PHASE4":1542,"NA":1603},{"trials":1521,"activeCount":82},[],{"trials":1523,"activeCount":82},[],{"trials":1525,"activeCount":82},[1526,1536],{"nctId":1527,"briefTitle":1528,"status":292,"phases":1529,"primaryCompletion":1530,"completion":1530,"start":1531,"enrollment":407,"conditions":1532,"interventions":1535},"NCT03138668","Cutaneous Anesthesia of the Lateral Femoral Cutaneous Nerve",[72],"2017-06-09","2017-05-19",[409,18,410,411,1533,1534],"Nervus Cutaneous Femoris Lateralis","Lateral Femoral Cutaneous Nerve",[300,300],{"nctId":374,"briefTitle":375,"status":292,"phases":1537,"primaryCompletion":377,"completion":377,"start":378,"enrollment":114,"conditions":1538,"interventions":1539},[72],[25],[381,300,365],{"trials":1541,"activeCount":82},[],{"trials":1543,"activeCount":82},[1544,1548,1557,1561,1570,1574,1578,1582,1586,1595,1599],{"nctId":290,"briefTitle":291,"status":292,"phases":1545,"primaryCompletion":294,"completion":294,"start":295,"enrollment":296,"conditions":1546,"interventions":1547},[74],[20,298],[300,265],{"nctId":1549,"briefTitle":1550,"status":292,"phases":1551,"primaryCompletion":1552,"completion":1552,"start":1553,"enrollment":407,"conditions":1554,"interventions":1556},"NCT05023343","Transmucular Quadratus Lumborum Block: Potential Quadriceps Muscle Weakness",[74],"2021-11-28","2021-10-02",[1555],"Neuromuscular Blockade",[300],{"nctId":302,"briefTitle":303,"status":292,"phases":1558,"primaryCompletion":305,"completion":306,"start":307,"enrollment":308,"conditions":1559,"interventions":1560},[74],[20],[300,311,312,265],{"nctId":1562,"briefTitle":1563,"status":192,"phases":1564,"primaryCompletion":1565,"completion":1565,"start":1566,"enrollment":1567,"conditions":1568,"interventions":1569},"NCT05753397","ITP Block: Single or Multiple Injection?",[74],"2023-03-05","2023-02-26",12,[18],[300],{"nctId":314,"briefTitle":315,"status":292,"phases":1571,"primaryCompletion":317,"completion":317,"start":318,"enrollment":319,"conditions":1572,"interventions":1573},[74],[20],[300,265,311,322,312],{"nctId":600,"briefTitle":601,"status":292,"phases":1575,"primaryCompletion":603,"completion":603,"start":604,"enrollment":605,"conditions":1576,"interventions":1577},[74],[607,608],[300,587,610],{"nctId":324,"briefTitle":325,"status":292,"phases":1579,"primaryCompletion":327,"completion":327,"start":328,"enrollment":260,"conditions":1580,"interventions":1581},[74],[330],[300,265],{"nctId":402,"briefTitle":403,"status":292,"phases":1583,"primaryCompletion":405,"completion":405,"start":406,"enrollment":407,"conditions":1584,"interventions":1585},[74],[409,18,410,411],[300,365],{"nctId":1587,"briefTitle":1588,"status":192,"phases":1589,"primaryCompletion":939,"completion":1590,"start":1591,"enrollment":1287,"conditions":1592,"interventions":1594},"NCT04196270","The Minimal Effective Volume (MEV90) of Ropivacaine 0.75% for Ultrasound-guided Transmuscular Quadratus Lumborum Block",[74],"2020-11-01","2020-01-05",[1593],"Percutaneous Nephrolithotomy",[300],{"nctId":333,"briefTitle":334,"status":292,"phases":1596,"primaryCompletion":336,"completion":336,"start":337,"enrollment":338,"conditions":1597,"interventions":1598},[74],[20,18],[300,265],{"nctId":342,"briefTitle":343,"status":292,"phases":1600,"primaryCompletion":345,"completion":345,"start":346,"enrollment":347,"conditions":1601,"interventions":1602},[74],[20],[300,265],{"trials":1604,"activeCount":82},[1605],{"nctId":1606,"briefTitle":1607,"status":192,"phases":1608,"primaryCompletion":1609,"completion":1609,"start":1610,"enrollment":1611,"conditions":1612,"interventions":1613},"NCT04951752","Effect of the Transmuscular Quadratus Lumborum Block on Duration of Stay in Recovery",[],"2021-08-01","2021-04-14",307,[18],[300],{"intervention":1615,"totalTrials":167,"cells":1616},"Clopidogrel",{"EARLY_PHASE1":1617,"PHASE1":1619,"PHASE2":1621,"PHASE3":1623,"PHASE4":1625,"NA":1637},{"trials":1618,"activeCount":82},[],{"trials":1620,"activeCount":82},[],{"trials":1622,"activeCount":82},[],{"trials":1624,"activeCount":82},[],{"trials":1626,"activeCount":82},[1627],{"nctId":1628,"briefTitle":1629,"status":292,"phases":1630,"primaryCompletion":1631,"completion":1631,"start":1632,"enrollment":1633,"conditions":1634,"interventions":1636},"NCT03385538","Clopidogrel Response and CYP2C19 Genotype in Ischemic Stroke Patients",[74],"2017-07-30","2015-11-01",103,[1635],"Ischemic Stroke",[1615],{"trials":1638,"activeCount":82},[1639],{"nctId":1640,"briefTitle":1641,"status":504,"phases":1642,"primaryCompletion":1643,"completion":1643,"start":1644,"enrollment":1645,"conditions":1646,"interventions":1648},"NCT02093299","RIsk of Apoplexia Cerebri in CLOpidogrel Non-responders",[],"2016-11-22","2012-12",165,[1647],"Stroke",[1615],{"intervention":1650,"totalTrials":78,"cells":1651},"paricalcitol",{"EARLY_PHASE1":1652,"PHASE1":1654,"PHASE2":1656,"PHASE3":1658,"PHASE4":1660,"NA":1662},{"trials":1653,"activeCount":82},[],{"trials":1655,"activeCount":82},[],{"trials":1657,"activeCount":82},[],{"trials":1659,"activeCount":82},[],{"trials":1661,"activeCount":82},[],{"trials":1663,"activeCount":82},[1664],{"nctId":1665,"briefTitle":1666,"status":504,"phases":1667,"primaryCompletion":1668,"completion":1669,"start":1670,"enrollment":1671,"conditions":1672,"interventions":1675},"NCT00469599","Treatment of Secondary Hyperparathyroidism in the Uremic Patient",[75],"2010-09","2010-10","2007-07",86,[1673,1391,1674],"Secondary Hyperparathyroidism","Vitamin D Deficiency",[1650,1676],"alfacalcidol",{"intervention":1676,"totalTrials":78,"cells":1678},{"EARLY_PHASE1":1679,"PHASE1":1681,"PHASE2":1683,"PHASE3":1685,"PHASE4":1687,"NA":1689},{"trials":1680,"activeCount":82},[],{"trials":1682,"activeCount":82},[],{"trials":1684,"activeCount":82},[],{"trials":1686,"activeCount":82},[],{"trials":1688,"activeCount":82},[],{"trials":1690,"activeCount":82},[1691],{"nctId":1665,"briefTitle":1666,"status":504,"phases":1692,"primaryCompletion":1668,"completion":1669,"start":1670,"enrollment":1671,"conditions":1693,"interventions":1694},[75],[1673,1391,1674],[1650,1676],{"intervention":1696,"totalTrials":78,"cells":1697},"Antibiotic",{"EARLY_PHASE1":1698,"PHASE1":1700,"PHASE2":1702,"PHASE3":1704,"PHASE4":1706,"NA":1708},{"trials":1699,"activeCount":82},[],{"trials":1701,"activeCount":82},[],{"trials":1703,"activeCount":82},[],{"trials":1705,"activeCount":82},[],{"trials":1707,"activeCount":82},[],{"trials":1709,"activeCount":82},[1710],{"nctId":1711,"briefTitle":1712,"status":292,"phases":1713,"primaryCompletion":1714,"completion":1715,"start":1716,"enrollment":1717,"conditions":1718,"interventions":1720},"NCT04803422","Per Oral Versus Intravenous Postoperative Antibiotics After Surgery for Complicated Appendicitis.",[75],"2024-05-31","2024-06-30","2021-04-01",3193,[1719],"Complicated Appendicitis",[1696],{"intervention":1722,"totalTrials":78,"cells":1723},"Pain treatment",{"EARLY_PHASE1":1724,"PHASE1":1726,"PHASE2":1728,"PHASE3":1730,"PHASE4":1732,"NA":1734},{"trials":1725,"activeCount":82},[],{"trials":1727,"activeCount":82},[],{"trials":1729,"activeCount":82},[],{"trials":1731,"activeCount":82},[],{"trials":1733,"activeCount":82},[],{"trials":1735,"activeCount":82},[1736],{"nctId":1737,"briefTitle":1738,"status":292,"phases":1739,"primaryCompletion":1740,"completion":1741,"start":1742,"enrollment":1743,"conditions":1744,"interventions":1745},"NCT02340052","Pain Map DK: a Prospective Cohort Study of Pain Treatment in 500 Hip Arthroplasty Patients at Different Danish Hospitals",[],"2016-05","2016-06-01","2014-04",501,[20],[1722],{"intervention":1747,"totalTrials":78,"cells":1748},"NSAID",{"EARLY_PHASE1":1749,"PHASE1":1751,"PHASE2":1753,"PHASE3":1755,"PHASE4":1757,"NA":1759},{"trials":1750,"activeCount":82},[],{"trials":1752,"activeCount":82},[],{"trials":1754,"activeCount":82},[],{"trials":1756,"activeCount":82},[],{"trials":1758,"activeCount":82},[],{"trials":1760,"activeCount":82},[1761],{"nctId":1762,"briefTitle":1763,"status":292,"phases":1764,"primaryCompletion":1765,"completion":1765,"start":1766,"enrollment":1767,"conditions":1768,"interventions":1770},"NCT04448652","Does Omission of NSAIDs After Colorectal Cancer Operation Affect the Consumption of Opioids?",[],"2017-12-31","2015-01-01",502,[1769],"Colo-rectal Cancer",[1747],{"intervention":1772,"totalTrials":78,"cells":1773},"TAP block",{"EARLY_PHASE1":1774,"PHASE1":1776,"PHASE2":1778,"PHASE3":1780,"PHASE4":1782,"NA":1784},{"trials":1775,"activeCount":82},[],{"trials":1777,"activeCount":82},[],{"trials":1779,"activeCount":82},[],{"trials":1781,"activeCount":82},[],{"trials":1783,"activeCount":82},[],{"trials":1785,"activeCount":82},[1786],{"nctId":1787,"briefTitle":1788,"status":292,"phases":1789,"primaryCompletion":1790,"completion":1791,"start":1792,"enrollment":155,"conditions":1793,"interventions":1796},"NCT02132065","Unilateral Dual TAP (Transverses Abdominal Plane) Blok i Forbindelse Med Laparoskopisk Nyre Operation",[75],"2017-06","2017-06-01","2014-06",[1794,1795],"Laparoscopic Nephrectomy","TAP Block",[1772],{"intervention":1798,"totalTrials":78,"cells":1799},"Ethanol 70%",{"EARLY_PHASE1":1800,"PHASE1":1802,"PHASE2":1804,"PHASE3":1806,"PHASE4":1808,"NA":1810},{"trials":1801,"activeCount":82},[],{"trials":1803,"activeCount":82},[],{"trials":1805,"activeCount":82},[],{"trials":1807,"activeCount":82},[],{"trials":1809,"activeCount":82},[],{"trials":1811,"activeCount":82},[1812],{"nctId":1813,"briefTitle":1814,"status":192,"phases":1815,"primaryCompletion":1816,"completion":1817,"start":648,"enrollment":1818,"conditions":1819,"interventions":1822},"NCT05953675","Ethanol Lock and Risk of Catheter Related Blood Stream Infection in Patients With Haemodialysis Catheter",[75],"2024-12","2025-04",280,[1820,1821],"Hemodialysis Catheter-Associated Bacteremia","Hemodialysis Complication",[1798,1823],"Isotonic saline with heparin",{"intervention":1823,"totalTrials":78,"cells":1825},{"EARLY_PHASE1":1826,"PHASE1":1828,"PHASE2":1830,"PHASE3":1832,"PHASE4":1834,"NA":1836},{"trials":1827,"activeCount":82},[],{"trials":1829,"activeCount":82},[],{"trials":1831,"activeCount":82},[],{"trials":1833,"activeCount":82},[],{"trials":1835,"activeCount":82},[],{"trials":1837,"activeCount":82},[1838],{"nctId":1813,"briefTitle":1814,"status":192,"phases":1839,"primaryCompletion":1816,"completion":1817,"start":648,"enrollment":1818,"conditions":1840,"interventions":1841},[75],[1820,1821],[1798,1823]]